Company profilePharmaceutical#188 of 1,318 in Pakistan✓ No DRAP alerts

Vision Pharmaceuticals Pvt Ltd

Pharmaceutical company · 95 brands · 71 molecules

Ranked #84 of 101 companies in Antihistamines For Systemic Use

95 registered products 51 pharmaceutical brands 71 distinct molecules 0 DRAP alerts

Company overview

95
registered products
51
pharmaceutical brands
71
distinct molecules
6
therapeutic classes
0
DRAP alerts

Vision Pharmaceuticals Pvt Ltd is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 95 product registrations across 71 distinct molecules. It is the 188th largest registrant in Pakistan by product count, and ranks 84th of 101 in Antihistamines For Systemic Use. Its portfolio is concentrated in Antihistamines For Systemic Use and Quinolone Antibacterials. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Vision

31 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

31
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202631

Top molecules by brand count

Linezolid7 brands
Azithromycin3 brands
Piperacillin3 brands
Sterile Water For Injection3 brands
Amikacin3 brands

Therapeutic classes

Antihistamines For Systemic Use · 1Quinolone Antibacterials · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Macrolides, Lincosamides And Streptogramins · 1Solutions For Parenteral Nutrition · 1Aminoglycoside Antibacterials · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official112 products · Rs 14.72 – Rs 22,510.18
Median across source: Rs 291.2

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Global Pharmaceuticals Pakistan holds 136 molecules not in this portfolio
AmikacinAmlodipineAmocycillinAmoxicillinAmoxicillin AmoxicillintrihydrateAmoxycillin
HIGH - Q INTERNATIONAL holds 129 molecules not in this portfolio
000 I.UAcetyl L-CarnitineAmikacinAmlodipineAnastrozoleAprepitant
MACTER INTERNATIONAL (PVT) LTD. holds 171 molecules not in this portfolio
000 I.U10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium Hydroxide

Get the full profile for Vision

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.